Adverum Biotechnologies, Inc. financial data

Symbol
ADVM on Nasdaq
Location
Redwood City, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 240% % -71%
Debt-to-equity 2186% % 2719%
Return On Equity -3476% % -3517%
Return On Assets -152% % -181%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22,077,467 shares 6.1%
Common Stock, Shares, Outstanding 20,848,000 shares 106%
Entity Public Float $136,700,000 USD -9.9%
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 23,487,000 shares 13%
Weighted Average Number of Shares Outstanding, Diluted 23,487,000 shares 13%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $0 USD -100%
Research and Development Expense $128,880,000 USD 89%
General and Administrative Expense $59,837,000 USD 6.3%
Operating Income (Loss) $188,717,000 USD -53%
Nonoperating Income (Expense) $1,202,000 USD -41%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $130,927,000 USD -6.3%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $184,793,000 USD -61%
Earnings Per Share, Basic -8 USD/shares -21%
Earnings Per Share, Diluted -8 USD/shares -21%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $26,060,000 USD -72%
Cash, Cash Equivalents, and Short-term Investments $26,100,000 USD -83%
Assets, Current $28,909,000 USD -82%
Property, Plant and Equipment, Net $10,462,000 USD -14%
Operating Lease, Right-of-Use Asset $29,031,000 USD -14%
Other Assets, Noncurrent $2,023,000 USD 56%
Assets $72,401,000 USD -66%
Accounts Payable, Current $12,459,000 USD 490%
Liabilities, Current $44,749,000 USD 98%
Operating Lease, Liability, Noncurrent $83,126,000 USD 4.7%
Other Liabilities, Noncurrent $179,000 USD
Liabilities $128,054,000 USD 26%
Accumulated Other Comprehensive Income (Loss), Net of Tax $440,000 USD -64%
Retained Earnings (Accumulated Deficit) $1,210,813,000 USD -18%
Stockholders' Equity Attributable to Parent $55,653,000 USD -151%
Liabilities and Equity $72,401,000 USD -66%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $42,771,000 USD -84%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $31,280,000 USD
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 20,848,000 shares 106%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $11,491,000 USD -115%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $28,036,000 USD -70%
Deferred Tax Assets, Valuation Allowance $232,058,000 USD 13%
Deferred Tax Assets, Gross $240,050,000 USD 11%
Operating Lease, Liability $88,940,000 USD
Payments to Acquire Property, Plant, and Equipment $220,000 USD 144%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $184,965,000 USD -62%
Lessee, Operating Lease, Liability, to be Paid $155,113,000 USD
Property, Plant and Equipment, Gross $29,213,000 USD -0.8%
Operating Lease, Liability, Current $5,814,000 USD 3.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two $15,278,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $13,471,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $66,173,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $15,677,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $137,140,000 USD 7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $27,188,000 USD 19%
Lessee, Operating Lease, Liability, to be Paid, Year Four $16,089,000 USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $7,992,000 USD -16%
Share-based Payment Arrangement, Expense $10,825,000 USD -29%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%